- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05339477
The Physical Activity Post Myocardial Infarction SWEDEHEART Prospective Cohort Study (ACTIVITY)
The Physical Activity Post Myocardial Infarction SWEDEHEART Prospective Cohort Study (ACTIVITY-SWEDEHEART)
The association between objectively measured physical activity intensities (light, moderate and vigorous), sedentary time and clinical outcomes has not been clarified in patients after a myocardial infarction.
The overall objective of the study is to explore associations between accelerometer measured physical activity and clinical outcomes after a myocardial infarction. Moreover, the association between changes in physical activity and outcomes will be assessed.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Maria Bäck, PhD
- Phone Number: +46313421195
- Email: maria.m.back@vgregion.se
Study Contact Backup
- Name: Johanna Lilliecrona, MSc
- Phone Number: +46313421195
- Email: johanna.lilliecrona@vgregion.se
Study Locations
-
-
-
Alingsås, Sweden
- Recruiting
- Alingsas lasarett
-
Contact:
- Petter Tollemark
-
Bollnäs, Sweden
- Recruiting
- Bollnäs sjukhus
-
Contact:
- Maria Östman
-
Bäckefors, Sweden
- Recruiting
- NU-sjukvården Dalslands sjukhus
-
Contact:
- Madelene Andersson
- Email: madelene.l.backstrom@vgregion.se
-
Eksjö, Sweden
- Recruiting
- Höglandssjukhuset Eksjö
-
Contact:
- Helene Warin
-
Enköping, Sweden
- Recruiting
- Lasarettet Enköping
-
Contact:
- Görel Stengård
-
Gothenburg, Sweden
- Recruiting
- Sahlgrenska University Hospital Sahlgrenska
-
Contact:
- Maria Lachonius, RN
- Email: maria.lachonius@vgregion.se
-
Gävle, Sweden
- Not yet recruiting
- Gävle sjukhus
-
Contact:
- Anna Cutler
-
Helsingborg, Sweden
- Recruiting
- Helsingborgs Lasarett
-
Contact:
- Bjarne Madsen Härdig
-
Jönköping, Sweden
- Recruiting
- Jönköping Ryhov Hospital
-
Contact:
- Emma Hag, RN
- Email: emma.hag@rjl.se
-
Kalix, Sweden
- Recruiting
- Kalix sjukhus
-
Contact:
- Magdalena Engren Jonsson
-
Kalmar, Sweden
- Recruiting
- Länssjukhuset Kalmar
-
Contact:
- Charlotta Lans
-
Karlstad, Sweden
- Recruiting
- Centralsjukhuset Karlstad
-
Contact:
- Karin Arinell
-
Katrineholm, Sweden
- Recruiting
- Kullbergska sjukhuset
-
Contact:
- Hanna Hafström Eng
-
Köping, Sweden
- Recruiting
- Västmanlands sjukhus Köping
-
Contact:
- Marianne Ordell Schieman
-
Linköping, Sweden
- Recruiting
- Universitetssjukhuset Linköping
-
Contact:
- Sabina Borg
-
Luleå, Sweden
- Recruiting
- Sunderby Sjukhus
-
Contact:
- Maarit Kylmamaa
-
Lysekil, Sweden
- Recruiting
- NU-sjukvården Lysekil
-
Contact:
- Marica Stenström
-
Malmö, Sweden
- Recruiting
- Skåne Universitetssjukhus Malmö
-
Contact:
- Margret Leosdottir
-
Norrköping, Sweden
- Withdrawn
- Vrinnevisjukhuset
-
Oskarshamn, Sweden
- Recruiting
- Oskarshamns sjukhus
-
Contact:
- Sofi Karlsson
-
Sala, Sweden
- Recruiting
- Västmanlands sjukhus Sala
-
Contact:
- Marica Hallsten Larsson
-
Sandviken, Sweden
- Recruiting
- Sandvikens sjukhus
-
Contact:
- Anna Cutler
-
Simrishamn, Sweden
- Recruiting
- Capio Närsjukhus Simrishamn
-
Contact:
- Pernilla Rosberg Håkansson
-
Skövde, Sweden
- Recruiting
- Skaraborgs Sjukhus Skövde
-
Contact:
- Frida Brevitz
-
Stockholm, Sweden
- Recruiting
- Södersjukhuset
-
Contact:
- Robin Hofmann
-
Stockholm, Sweden
- Recruiting
- Karolinska University Hospital Solna and Huddinge
-
Contact:
- Matthias Lidin, PhD
- Email: matthias.lidin@ki.se
-
Stockholm, Sweden
- Recruiting
- Capio St Göran
-
Contact:
- Anneli Johansson
-
Strömstad, Sweden
- Recruiting
- NU-sjukvården Strömstad
-
Contact:
- Barbro Limnell
-
Söderhamn, Sweden
- Not yet recruiting
- Söderhamns sjukhus
-
Contact:
- Anna-Sara Raphael
-
Umeå, Sweden
- Active, not recruiting
- Norrlands Universitetssjukhus Umeå
-
Uppsala, Sweden
- Recruiting
- Akademiska Sjukhuset
-
Contact:
- Emil Hagström
-
Varberg, Sweden
- Recruiting
- Hallands sjukhus Varberg
-
Contact:
- Frida Johansson
-
Visby, Sweden
- Not yet recruiting
- Visby Lasarett
-
Contact:
- Amanda Wiberg
- Email: amanda.wiberg@gotland.se
-
Värnamo, Sweden
- Recruiting
- Värnamo sjukhus
-
Contact:
- Monica Cederblad
-
Västervik, Sweden
- Recruiting
- Västerviks sjukhus
-
Contact:
- Emmy Cheruiyot Johansson
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Signed informed consent
- Diagnosis of a type 1 myocardial infarction registered in SWEDEHEART
- Age 18-79 years at discharge from hospital
- Attending the first visit in the cardiac rehabilitation (CR) registry SEPHIA (2 months after discharge)
Exclusion Criteria:
- Inability to understand Swedish
- Non-ambulatory
- Any mental condition that may interfere with the possibility for the patient to comply with the study protocol
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Cohort group
Diagnosis of a type 1 myocardial infarction registered in SWEDEHEART Age 18-79 years at discharge from hospital
|
Study personnel will initiate an accelerometer and inform the patient to wear the accelerometer with an elastic belt on their right hip during waking hours for seven consecutive days.
Moreover, patients are instructed to register their wear time in an activity diary in paper form.
In addition, patients will register their working hours, if relevant.
After seven days, patients send back the accelerometer and diary in a pre-paid envelope.
The same procedure is repeated at the second follow-up visit at 1 year.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Major adverse cardiovascular event (MACE)
Time Frame: 1 year after the index cardiac event
|
The composite incidence of cardiovascular mortality, non-fatal myocardial infarction, non-fatal ischemic stroke, coronary revascularization, hospitalization for new or worsening heart failure
|
1 year after the index cardiac event
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cardiovascular mortality
Time Frame: 1 year after the index cardiac event
|
Incidence of cardiovascular mortality
|
1 year after the index cardiac event
|
|
Non-fatal myocardial infarction
Time Frame: 1 year after the index cardiac event
|
Incidence of non-fatal myocardial infarction
|
1 year after the index cardiac event
|
|
Non-fatal ischemic stroke
Time Frame: 1 year after the index cardiac event
|
Incidence of non-fatal ischemic stroke
|
1 year after the index cardiac event
|
|
Coronary revascularization
Time Frame: 1 year after the index cardiac event
|
Incidence of coronary revascularization
|
1 year after the index cardiac event
|
|
Heart failure
Time Frame: 1 year after the index cardiac event
|
Incidence of hospitalization for new or worsening heart failure
|
1 year after the index cardiac event
|
|
Major adverse cardiovascular event (MACE)
Time Frame: 3 years after the index cardiac event
|
The composite incidence of cardiovascular mortality, non-fatal myocardial infarction, non-fatal ischemic stroke, coronary revascularization, hospitalization for new or worsening heart failure
|
3 years after the index cardiac event
|
|
Cardiovascular mortality
Time Frame: 3 years after the index cardiac event
|
Incidence of cardiovascular mortality
|
3 years after the index cardiac event
|
|
Non-fatal myocardial infarction
Time Frame: 3 years after the index cardiac event
|
Incidence of non-fatal myocardial infarction
|
3 years after the index cardiac event
|
|
Non-fatal ischemic stroke
Time Frame: 3 years after the index cardiac event
|
Incidence of non-fatal ischemic stroke
|
3 years after the index cardiac event
|
|
Coronary revascularization
Time Frame: 3 years after the index cardiac event
|
Incidence of coronary revascularization
|
3 years after the index cardiac event
|
|
Heart failure
Time Frame: 3 years after the index cardiac event
|
Incidence of hospitalization for new or worsening heart failure
|
3 years after the index cardiac event
|
|
All-cause death
Time Frame: 1 year after the index cardiac event
|
Incidence of all-cause death
|
1 year after the index cardiac event
|
|
All-cause death
Time Frame: 3 year after the index cardiac event
|
Incidence of all-cause death
|
3 year after the index cardiac event
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Smoking status
Time Frame: 1 year after the index cardiac event
|
0=Never smoker, 1=Former smoker > 1 month, 2=Smoker
|
1 year after the index cardiac event
|
|
The Swedish Healthy diet questionnaire
Time Frame: 1 year after the index cardiac event
|
Four questions with Likert scale 0-3 points.
Higher scores indicate better outcomes
|
1 year after the index cardiac event
|
|
Health-related quality of life (EuroQol- 5 Dimension)
Time Frame: 1 year after the index cardiac event
|
EuroQol- 5 Dimension (EQ-5D-3L) The EQ-5D-3L comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 3 levels: no problems, some problems, and extreme problems.
Higher scores indicate better outcomes.
|
1 year after the index cardiac event
|
|
Health-related quality of life (EQ visual analogue scale)
Time Frame: 1 year after the index cardiac event
|
EQ visual analogue scale (EQ VAS).
The EQ VAS records the respondent's self-rated health on a vertical, visual analogue scale where the endpoints are labelled 'Best imaginable health state' and 'Worst imaginable health state'.
|
1 year after the index cardiac event
|
|
Triglycerides
Time Frame: 1 year after the index cardiac event
|
Plasma levels of triglycerides (mmol/L).
Higher values indicate worse outcome.
|
1 year after the index cardiac event
|
|
High-density lipoprotein (HDL) cholesterol
Time Frame: 1 year after the index cardiac event
|
Plasma levels of HDL (mmol/L).
Higher values indicate better outcome
|
1 year after the index cardiac event
|
|
Low-density lipoprotein (LDL) cholesterol
Time Frame: 1 year after the index cardiac event
|
Plasma levels of LDL cholesterol (mmol/L).
Higher values indicate worse outcome
|
1 year after the index cardiac event
|
|
Hemoglobin A1c (HbA1c)
Time Frame: 1 year after the index cardiac event
|
HbA1c (mmol/L).
Measures the amount of blood sugar.
Higher values indicate worse outcome
|
1 year after the index cardiac event
|
|
Blood pressure
Time Frame: 1 year after the index cardiac event
|
mmHg
|
1 year after the index cardiac event
|
|
Body weight
Time Frame: 1 year after the index cardiac event
|
kg
|
1 year after the index cardiac event
|
|
Waist circumference
Time Frame: 1 year after the index cardiac event
|
cm
|
1 year after the index cardiac event
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Maria Bäck, PhD, Department of physiotherapy, Sahlgrenska University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 277371
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Myocardial Infarction
-
Beijing Northland Biotech. Co., Ltd.Not yet recruitingAcute Myocardial Infarction (AMI) | Acute Myocardial Infarction of Anterior Wall | Acute Myocardial Infarction With ST Elevation | Acute Myocardial Infarction With ST Segment Elevation | Acute Myocardial Infarction of Left VentricleChina
-
Azienda ULSS 5 PolesanaUniversity of PadovaUnknownMyocardial Infarction, Acute | ST Segment Elevation Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Italy
-
University Medical Centre LjubljanaCompletedCardiac Arrest | Postresuscitation Syndrome | Myocardial Infarction (ST-Elevation Myocardial Infarction and Non-ST-Elevation Myocardial Infarction)Slovenia
-
Fundacio Privada Mon Clinic BarcelonaMiracor Medical SAWithdrawn
-
Samsung Medical CenterThe Korean Society of CardiologyNot yet recruiting
-
Stiftung Institut fuer HerzinfarktforschungGlaxoSmithKline; University Hospital Muenster; Klinikum NürnbergCompletedMyocardial Infarction | ST-Elevation Myocardial Infarction | Non-ST-Elevation Myocardial InfarctionGermany
-
Harbin Medical UniversityNot yet recruitingNon-stenting Treatment Strategy for Acute Myocardial Infarction With Non-severe Stenosis(EROSION IV)Acute Myocardial Infarction (AMI) | ST-Segment Elevation Myocardial Infarction(STEMI) | Non-ST-Segment Elevation Myocardial Infarction(NSTEMI)China
-
Bispebjerg HospitalOdense University Hospital; Zealand University Hospital; Aarhus University Hospital and other collaboratorsActive, not recruitingST Elevation Myocardial Infarction | Acute Myocardial Infarction | Non-ST Elevation Myocardial Infarction (nSTEMI)Denmark
-
Population Health Research InstituteCanadian Institutes of Health Research (CIHR); Boston Scientific CorporationCompletedST Elevation Myocardial Infarction | Non ST Elevation Myocardial InfarctionUnited States, Spain, Netherlands, Canada, Australia, Serbia, Egypt, Switzerland, Hungary, United Kingdom, France, Czechia, Nepal, North Macedonia
-
Chonnam National University HospitalNot yet recruitingMyocardial Infarction (MI) | AF - Atrial Fibrillation | NSTEMI - Non-ST-Segment Elevation Myocardial Infarction | ST-Segment Elevation Myocardial Infarction(STEMI)South Korea
Clinical Trials on Accelerometer measurement
-
Bassett HealthcareCompletedEarly Mobilization of Mechanically Ventilated PatientsUnited States
-
Simon JägerLMU Klinikum; SLK Kliniken Heilbronn GmbH; Robert Bosch Medical Center; Klinikum...RecruitingPulmonary Hypertension | Precapillary Pulmonary Hypertension | Right Heart Catheterisation | Digital Mobility OutcomesGermany
-
University of Southern CaliforniaNational Cancer Institute (NCI)CompletedSolid NeoplasmUnited States
-
University of East AngliaUnknown
-
University Hospital, LimogesActive, not recruiting
-
PepsiCo Global R&DCompletedSleep Quantity | Sleep EfficiencyUnited States
-
Mayo ClinicJR Albert FoundationCompleted
-
Centre Hospitalier Universitaire de Saint EtienneTerminated
-
Hull University Teaching Hospitals NHS TrustCompletedCritical Care | Walking | PostureUnited Kingdom
-
Ann & Robert H Lurie Children's Hospital of ChicagoCompletedPhysical Activity | SurgeryUnited States